HS016, a biosimilar candidate of Humira (adalimumab), was seen to have equivalent safety and effectiveness at…
Articles by Ana Pena, PhD
Women with ankylosing spondylitis (AS) and other inflammatory conditions who take TNF inhibitors during pregnancy may…
Rinvoq (upadacitinib), an oral therapy recently approved for rheumatoid arthritis, was effective in treating adults with active…
Biogen has signed an agreement with Samsung Bioepis that includes an option of extending commercialization rights to three biosimilars…
Men, people who are employed, have a lower income, perceive less control over their lives, and are less satisfied…
Eli Lilly‘s Taltz (ixekizumab) has been approved by the U.S. Food and Drug Administration (FDA) for the…
Total hip replacement surgery, or hip arthroplasty, has doubled in older patients with ankylosing spondylitis (AS), outpacing the…
Percutaneous interbody fusion (PIF), a minimally invasive and potentially safer procedure, is feasible to stabilize spinal fractures due…
TNF inhibitors, or blockers, are safer than previously thought for patients with ankylosing spondylitis (AS) and may…
Both the lifetime risk of valvular heart disease (VHD) and the need for pacemakers markedly increase with age for…